男性丛集性头痛患者存在代偿性性腺功能减退:一项前瞻性病例对照研究
这项前瞻性病例对照研究纳入60例发作性丛集性头痛患者(发作期和缓解期)、60例慢性丛集性头痛患者和60例年龄性别匹配的健康对照,检测睾酮、促黄体生成素(LH)和性激素结合球蛋白。校正年龄、睡眠时长和急性药物使用后,慢性丛集性头痛患者游离睾酮/LH比值较对照降低35%(95%CI:21%-47%,p<0.0001),发作性丛集性头痛患者降低24%(95%CI:9%-37%,p=0.004);发作期与缓解期雄激素浓度无差异。研究还发现游离睾酮与丛集性头痛共享遗传风险等位基因rs112572874。
要点
- 慢性丛集性头痛男性患者游离睾酮/LH比值较健康对照降低35%(95%CI:21%-47%,p<0.0001)。
- 发作性丛集性头痛男性患者游离睾酮/LH比值较健康对照降低24%(95%CI:9%-37%,p=0.004)。
- 丛集性头痛患者发作期与缓解期雄激素浓度无差异。
核心结论
- 男性丛集性头痛患者内分泌系统改变为代偿性性腺功能减退状态,且并非与睡眠或急性药物使用相关的伴随现象。
- 结合所发现的共享遗传风险等位基因,这提示丛集性头痛与游离睾酮之间可能存在病理生理联系。
研究设计与样本
- 前瞻性病例对照研究,纳入成年男性:60例发作性丛集性头痛患者(发作期和缓解期)、60例慢性丛集性头痛患者和60例年龄性别匹配的健康对照。
- 检测血清睾酮、促黄体生成素(LH)和性激素结合球蛋白,游离睾酮按Vermeulen方程计算。
- 评估丛集性头痛与睾酮浓度之间的共享遗传风险变异。
主要发现
- 校正年龄、睡眠时长和急性药物使用后,慢性丛集性头痛患者游离睾酮/LH比值较对照降低35%(95%CI:21%-47%,p<0.0001)。
- 校正年龄、睡眠时长和急性药物使用后,发作性丛集性头痛患者游离睾酮/LH比值较对照降低24%(95%CI:9%-37%,p=0.004)。
- 丛集性头痛患者发作期与缓解期雄激素浓度无差异。
- 发现游离睾酮与丛集性头痛共享遗传风险等位基因rs112572874,位于17号染色体微管相关蛋白tau(MAPT)基因内含子。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Androgens have been hypothesized to be involved in the pathophysiology of cluster headache due to the male predominance, but whether androgens are altered in patients with cluster headache remains unclear. METHODS: We performed a prospective, case-controlled study in adult males with cluster headache. Sera were measured for hormones including testosterone, luteinizing hormone (LH), and sex hormone-binding globulin in 60 participants with episodic cluster headache (during a bout and in remission), 60 participants with chronic cluster headache, and 60 age- and sex-matched healthy controls. Free testosterone (fT) was calculated according to the Vermeulen equation. Shared genetic risk variants were assessed between cluster headache and testosterone concentrations. RESULTS: The mean fT/LH ratio was reduced by 35% (95% confidence interval [CI]: 21%-47%, p < 0.0001) in patients with chronic cluster headache and by 24% (95% CI: 9%-37%, p = 0.004) in patients with episodic cluster headache compared to controls after adjusting for age, sleep duration, and use of acute medication. Androgen concentrations did not differ between bouts and remissions. Furthermore, a shared genetic risk allele, rs112572874 (located in the intron of the microtubule associated protein tau (MAPT) gene on chromosome 17), between fT and cluster headache was identified. INTERPRETATION: Our results demonstrate that the male endocrine system is altered in patients with cluster headache to a state of compensated hypogonadism, and this is not an epiphenomenon associated with sleep or the use of acute medication. Together with the identified shared genetic risk allele, this may suggest a pathophysiological link between cluster headache and fT. ANN NEUROL 2024;95:1149-1161.
引用
- Petersen AS, Kristensen DM, Westgate CSJ, et al. Compensated Hypogonadism Identified in Males with Cluster Headache: A Prospective Case-Controlled Study. Ann Neurol. 2024. PMID: 38558306. doi:10.1002/ana.26906
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。